Literature DB >> 18572420

The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.

Osama I I Soliman1, Bas M van Dalen, Dominic A M J Theuns, Folkert J ten Cate, Attila Nemes, Luc J Jordaens, Marcel L Geleijnse.   

Abstract

AIM OF THE STUDY: The aim of this study was to evaluate reverse volumetric left ventricular (LV) remodeling after cardiac resynchronization therapy (CRT) in patients with heart failure (HF) with vs. without diabetes mellitus (DM).
METHODS: The study comprised 130 consecutive patients with HF (mean age, 61+/-12 years) who underwent CRT. Thirty patients (23%) had DM [mean glycated haemoglobin (HbA(1c)), 7.2+/-3.4%; 13 (43%) on insulin therapy]. Echocardiography, including tissue Doppler measurements, was performed before CRT and between 3 and 6 months after CRT. Echocardiographic response was defined as a >15% reduction in LV end-systolic volume (ESV).
RESULTS: Patients with DM had more often hypertension (60% vs. 29%, P<.05) and ischemic HF etiology (87% vs. 51%, P<.05), but similar pre-CRT echocardiographic findings. After CRT, patients with DM had equal reductions in QRS duration and lateral-to-septal mechanical delay, but less improvement in LV ESV, mitral annular tissue velocity, the myocardial performance (or Tei) index and the E/E' ratio (ratio of early transmitral peak filling velocity to early mitral annular peak diastolic velocity, an indicator of LV filling pressure). Patients without reverse volumetric LV remodeling had more often DM [hazard ratio (HR), 1.897; P=.042] and an ischemic HF etiology (HR, 2.308; P=.006). An ischemic HF etiology (HR, 2.119; P=.018) was the only independent predictor of poor reverse volumetric LV remodeling.
CONCLUSION: Ischemic etiology of HF is an independent predictor of poor echocardiographic response to CRT. Patients with DM and HF have a relatively poor echocardiographic response to CRT most probably due to a high incidence of ischemic etiology of HF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572420     DOI: 10.1016/j.jdiacomp.2008.04.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

1.  Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people.

Authors:  Celestino Sardu; Raffaele Marfella; Gaetano Santulli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-06       Impact factor: 4.132

2.  Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.

Authors:  Sandra Amorim; João Rodrigues; Manuel Campelo; Brenda Moura; Elisabete Martins; Filipe Macedo; J Silva-Cardoso; M Júlia Maciel
Journal:  Int J Cardiovasc Imaging       Date:  2016-12-24       Impact factor: 2.357

Review 3.  Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death.

Authors:  Muhammad Shahreyar; Vijayadershan Mupiddi; Indrajit Choudhuri; Jasbir Sra; Abdul Jamil Tajik; Arshad Jahangir
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-22

4.  The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality.

Authors:  Dominic A M J Theuns; Beat A Schaer; Osama I I Soliman; David Altmann; Christian Sticherling; Marcel L Geleijnse; Stefan Osswald; Luc Jordaens
Journal:  Europace       Date:  2010-09-10       Impact factor: 5.214

Review 5.  Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis.

Authors:  Hui Sun; Yuqing Guan; Lei Wang; Yong Zhao; Hong Lv; Xiuping Bi; Huating Wang; Xuejing Zhang; Li Liu; Min Wei; Hui Song; Guohai Su
Journal:  BMC Cardiovasc Disord       Date:  2015-03-21       Impact factor: 2.298

6.  Effects of Trimetazidine on T Wave Alternans in Stable Coronary Artery Disease.

Authors:  Mehmet Yaman; Uğur Arslan; Hasan Ali Gümrükçüoğlu; Musa Şahin; Hakkı Şimşek; Serkan Akdağ
Journal:  Korean Circ J       Date:  2016-04-26       Impact factor: 3.243

7.  Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy.

Authors:  Ulas Höke; Joep Thijssen; Rutger J van Bommel; Lieselot van Erven; Enno T van der Velde; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Diabetes Care       Date:  2012-12-05       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.